Intussusception in a term newborn with duct-dependent congenital heart disease

Creative Commons License

Aydın B., Dilli D., Zenciroğlu A., Erdoğan D., Karaman I., Ipek M. Ş., ...Daha Fazla

Dicle Medical Journal , cilt.40, sa.1, ss.105-108, 2013 (Hakemli Dergi)

  • Yayın Türü: Makale / Vaka Takdimi
  • Cilt numarası: 40 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5798/diclemedj.0921.2013.01.0233
  • Dergi Adı: Dicle Medical Journal
  • Derginin Tarandığı İndeksler: EBSCO Education Source
  • Sayfa Sayıları: ss.105-108
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

ABSTRACT Prostaglandin E1 infusion is widely used to maintain patency of ductus arteriosus in newborns with duct-dependent congenital heart disease until surgery. Prostaglandin E1 is a lifesaving drug, but it has many side effects including fever, apnea, bradycardia, hypotension, convulsion, edema, and cortical hyperostosis. The gastrointestinal tract has not been recognized as a major site of serious adverse effects of prostaglandin E1 infusion, although diarrhea is a well-recognized side effect that usually responds to dose reduction. In this report, we present a case of intestinal intussusception presumably induced by prostaglandin therapy in a newborn with duct-dependent congenital heart disease. Key words: Prostaglandin E1, newborn, gastrointestinal